Stephanie Morfessis, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1919 N Broadway, Baltimore, MD 21213 Phone: 443-884-4745 |
Mrs. Jennifer L Pritchard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1750 E Fairmount Ave, Baltimore, MD 21231 Phone: 443-923-9100 |
Janine S Eikenberg, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 707 N Broadway, Baltimore, MD 21205 Phone: 443-923-1886 |
Mrs. Jennifer Pannone Sharpless, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 707 N. Broadway, Baltimore, MD 21205 Phone: 443-923-9200 |
Mrs. Samantha Rae Dutta Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9150 Franklin Square Dr, Baltimore, MD 21237 Phone: 443-809-0422 |
Ms. Marci Weinberg Burt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 W 40th St, Baltimore, MD 21211 Phone: 410-235-8860 |
Aviva Mond, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Walker Ave, Baltimore, MD 21208 Phone: 410-415-3515 |
Carson Wood Fisher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5910 Craigmont Rd, Baltimore, MD 21228 Phone: 410-887-0823 |
Jennifer Liszewski Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6451 N Charles St, Baltimore, MD 21212 Phone: 877-407-3422 Fax: 877-407-4329 |
Hindy Cin, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 121 Mcmechen St, Baltimore, MD 21217 Phone: 443-208-6593 |
Bethany A Carr, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 707 N Broadway, Baltimore, MD 21205 Phone: 443-923-1886 |
Emily E Tyson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 707 N Broadway, Baltimore, MD 21205 Phone: 443-923-1886 |
Dr. Pamela Anne Mathy, PHD CCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3901 Greenspring Ave, Baltimore, MD 21211 Phone: 443-923-7880 |
Mrs. Jaimee Tyson-mcomie, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 509 S Exeter St, Baltimore, MD 21202 Phone: 877-804-6222 |
Meghan Madura, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2931 E Biddle St, Patient Accounting, Baltimore, MD 21213 Phone: 443-923-1872 |
Beth Steinberg Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2406 Hal Cir, Baltimore, MD 21209 Phone: 410-916-1359 |
Ms. Laura Michele Ciattei, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7 Burl Ct, Baltimore, MD 21234 Phone: 443-465-5527 |
Lauren Ashley Jensen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3320 Benson Ave, Baltimore, MD 21227 Phone: 410-644-7100 |
Christine Smith, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5900 Metro Dr, Baltimore, MD 21215 Phone: 410-318-6780 Fax: 410-318-6759 |
Mrs. Lauren E Valente, M.S, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3835 Greenspring Ave, Baltimore, MD 21211 Phone: 443-923-4592 |
News Archive
Leading futurists and technologists have worked with the National Academy of Engineering (NAE) to identify "Grand Challenges for Engineering in the 21st Century," focusing on technological breakthroughs needed to build sustainable societies and improve the quality of life in a growing and increasingly complex world.
A new study conducted at the Hamot Medical Center in Erie, Pennsylvania, and published by Elsevier in the February 2009 issue of The Journal of Emergency Medicine shows that there is a lack of education and understanding in what sets a living will in motion in a pre-hospital setting. Education and implementation of code status designations can clarify this confusion.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA® (suvorexant) for adults with insomnia who have difficulty falling asleep and/or staying asleep. BELSOMRA (pronounced bell-SOM-rah) is a highly selective antagonist for orexin receptors.
Organized by IQPC, the 8th Annual Polymorphism & Crystallization Scientific Forum will be held October 26-28, 2009 at the Hub Cira Center in Philadelphia, PA (www.polymorphismforum.com).
› Verified 3 days ago